ArticleBioinformatics (Oxford, England)2025
OrthologAL: a Shiny application for quality-aware humanization of non-human pre-clinical high-dimensional gene expression data.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- RAC1 regulates Sonic Hedgehog-medulloblastoma growth via GLI-mediated transcription.Neuro-oncology · 2026Article
- Drug and single-cell gene expression integration identifies sensitive and resistant glioblastoma cell populations.Nature communications · 2026Article
- Single-cell sequencing reveals cellular heterogeneity and molecular mechanisms in tendon and enthesis injury repair.Frontiers in physiology · 2025Review
Corrections and comments
- Update of
Authors and funding
8 authors.
Funding
Abstract
motivationSingle-cell and spatial transcriptomics provide unprecedented insight into diseases. Pharmacotranscriptomic approaches are powerful tools that leverage gene expression data for drug repurposing and discovery. Multiple databases attempt to connect human cellular transcriptional responses to small molecules for use in transcriptome-based drug discovery efforts. However, preclinical research often requires in vivo experiments in non-human species, which makes utilizing such valuable resources difficult. To facilitate both human orthologous conversion of non-human transcriptomes and the application of pharmacotranscriptomic databases to pre-clinical research models, we introduce OrthologAL. OrthologAL interfaces with BioMart to access different gene sets from the Ensembl database, allowing for ortholog conversion without the need for user-generated code.
resultsResearchers can input their single-cell or other high-dimensional gene expression data from any species as a Seurat object, and OrthologAL will output a human ortholog-converted Seurat object for download and use. To demonstrate the utility of this application, we tested OrthologAL using single-cell, single-nuclei, and spatial transcriptomic data derived from common preclinical models, including patient-derived orthotopic xenografts of medulloblastoma, and mouse and rat models of spinal cord injury. OrthologAL can convert these data types efficiently to that of corresponding orthologs while preserving the dimensional architecture of the original non-human expression data. OrthologAL will be broadly useful for the simple conversion of Seurat objects and for applying preclinical, high-dimensional transcriptomics data to functional human-derived small molecule predictions. AVAILABILITY AND IMPLEMENTATION: OrthologAL is available for download as an R package with functions to launch the Shiny GUI at https://github.com/AyadLab/OrthologAL or via Zenodo at https://doi.org/10.5281/zenodo.15225041. The medulloblastoma single-cell transcriptomics data were downloaded from the NCBI Gene Expression Omnibus with the identifier GSE129730. 10X Visium data of medulloblastoma PDX mouse models from Vo et al. were acquired by contacting the authors, and the raw data are available from ArrayExpress under the identifier E-MTAB-11720. The single-cell and single-nuclei transcriptomics data of rat and mouse spinal-cord injury were acquired from the Gene Expression Omnibus under the identifiers GSE213240 and GSE234774.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.